🇺🇸 FDA
Patent

US 9181255

Fused heteroaromatic pyrrolidinones as SYK inhibitors

granted A61KA61K31/437A61K31/519

Quick answer

US patent 9181255 (Fused heteroaromatic pyrrolidinones as SYK inhibitors) held by Takeda Pharmaceutical Company Limited expires Mon Nov 05 2035 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.

Key facts

Applicant
Takeda Pharmaceutical Company Limited
Grant date
Tue Nov 10 2015 00:00:00 GMT+0000 (Coordinated Universal Time)
Expiration
Mon Nov 05 2035 00:00:00 GMT+0000 (Coordinated Universal Time)
Claims
28
CPC classes
A61K, A61K31/437, A61K31/519, A61K31/527, A61K45/06